ICCS 2020 - Virtual Event Agenda
Session Titles and List of Company Pitches from Promising Oncology Innovators
ICCS 2020's Virtual Event showcased emerging oncology companies advancing novel therapeutic, diagnostic, and digital solutions for cancer patients. The event featured four thematic sessions highlighting 20 companies from Massachusetts, Philadelphia, Quebec, the UK Golden Triangle, the Nordics, France, and Switzerland.
Session 1: Targeting Novel Mechanisms
Welcome from the ICCS 2020 Organizing Partners.
Session 2: I-O and Cell Therapy
Takeda Presentation, Alexandra Huhalov, Search & Evaluation Lead, Oncology, Center for External Innovation, Takeda Pharmaceuticals.
ICCS 2020 has been sponsored by: